Background/Aims: In recent years, microRNA-495 (miR-495) has been reported to be a tumor-suppressor miR that is down-modulated in cancers. However, its potential mechanism remains unknown. Therefore, this study aimed to demonstrate the role of miR-495 in cardiac microvascular endothelial cell (CMEC) injury and inflammatory reaction by mediating the pyrin domain-containing 3 (NLRP3) inflammasome signaling pathway. Methods: Overall, 40 mice were assigned into myocardial ischemia/reperfusion injury (MIR) and sham groups. After model establishment, the levels of troponin T (TnT), troponin I (TnI), N-terminal pro-B-type natriuretic peptide (NT-proBNP), creatine kinase isoenzyme MB (CK-MB), myoglobin (MYO), tumor necrosis factor-alpha (TNF-α), and interleukin 1beta (IL-1β) were detected by Enzyme-Linked Immunosorbent Assay (ELISA). Apoptosis was evaluated using Terminal deoxy (d)-UTP nick end labeling (TUNEL) staining, the level of NLRP3 protein was determined by immunohistochemical assay, and miR-495 was detected by in situ hybridization (ISH). The infarct size was determined using 2, 3, 5-triphenyltetrazolium chloride (TTC) staining. The expression of miR-495 and the mRNA and protein levels of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1 were evaluated by RT-qPCR and western blot analysis. After transfection, the cells were treated with a miR-495 mimic, a miR-495 inhibitor, or siNLRP3. Cell proliferation was measured by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay and cell cycle and apoptosis by flow cytometry. Results: Mice with myocardial I/R injury had elevated levels of TnT, TnI, NT-proBNP, CK-MB, MYO, TNF-α and IL-1β; enhanced cell apoptosis; increased expression of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1; and decreased miR-495 expression. MiR-495 was confirmed to target NLRP3. Moreover, miR-495 reduced the mRNA and protein levels of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1, inhibited cell apoptosis
Introduction
During myocardial ischemia-reperfusion, endothelial cells (ECs) are directly exposed to the hypoxia, which leads to injury [1] . For cell injury resulting from trauma, several procedures should be initiated simultaneously to achieve an acute inflammatory response designed to protect sustained tissue infection and damage and to recover and maintain tissue homeostasis [2] . Vessel endothelium injury due to reactive oxygen species plays a key role in the pathogenesis of cardiovascular disorders [3] . Myocardial ischemia-reperfusion injury is characterized as a major factor in the morbidity and mortality correlated with coronary artery disease [4] . Acute myocardial infarction is a major cause of disability and death worldwide [5] . Moreover, it induces a serious inflammatory response that is critical for cardiac repair, which is involved in the pathogenesis of heart failure and post-infarction remodeling [6] . Aging is correlated with an increased incidence of myocardial infarction and impaired angiogenesis when shaping new capillary blood vessels from preexisting vessels [7] . Myocardial infarction leads to cardiomyocyte loss, which considerably exceeds the limited regenerative capacity in the mammalian myocardium and causes high morbidity and mortality [8] . Although there have been advancements in the emergency treatment of myocardial infarction, its early mortality and morbidity remain high [9] . In addition, inflammatory responses play a major role in the processes of tumor development, including promotion, initiation, invasion, malignant conversion and metastasis, and they respond to therapy and influence immune surveillance [10] . A previous study has indicated that microRNA (miRs) modulate diverse aspects of heart disease, including heart failure, remodeling, hypertrophy, and arrhythmia [11] .
MiRs are defined as endogenous small RNAs of 21-25 nucleotides, which can pair with sites in 3' untranslated regions in mRNAs in protein-coding genes to downregulate their levels, and circulating miRNAs have been demonstrated as promising biomarkers for different pathologic situations [12] . MiR-495 was verified to be a tumor-suppressor miR that is downmodulated in the mixed lineage leukemia-rearranged leukemia [13] . In addition, miR-495 modulates proliferation and migration in non-small cell lung cancer by targeting metastasisassociated protein 3 [14] . The nucleotide-binding domain and leucine-rich repeat-containing (NLR) family, pyrin domain-containing 3 (NLRP3) inflammasome is a multiprotein complex that activates caspase 1, leading to the processing and secretion of the pro-inflammatory cytokines interleukin-1beta (IL-1beta) and IL-18 [15] . The NLRP3 inflammasome is characterized as a critical element of the innate immune system in realizing viral infection, but the mechanism by which viruses activate this inflammasome remains unclear [16] . The NLRP3 inflammasome activation is involved in several inflammatory diseases [17] . Moreover, as the NLRP3 inflammasome plays an important role in initiating acute sterile inflammation, a recent study has indicated that NLRP3 inflammasome up-modulates and mediates myocardial ischemia/reperfusion damage [18] . However, few studies have clarified the correlation among miR-495, NLRP3 and cardiac microvascular endothelial cell (CMEC) injury and inflammation. Thus, this study aims to discuss the effect of miR-495 on CMEC injury and inflammation reaction by mediating the NLRP3 inflammasome signaling pathway.
Model establishment
The C57BL/6 mice in the MIR group were fixed by dorsal decubitus and anaesthetized by intraperitoneal injection with 30 mg/kg pentobarbital sodium (P3761, Sigma-Aldrich, St Louis, MO, USA). The mice were connected with II lead electrocardiogram and disinfected by 75% absolute ethanol on the cervico-thoracic region. Next, a 1-cm median incision was made under the neck, and blunt separation of the anterior cervical muscle group was conducted along the midline, followed by trachea exposure. Then, the mice were given a tracheal cannula. After successful intubation, the tubes were fixed by bushing, and assisted respiration was conducted for the mice by connecting a breathing machine. A longitudinal incision was made in the left sternum of the mice, and the fourth costal cartilage was cut at approximately 0.5 cm from the left border of the sternum to expose the heart. The non-invasive needle was used to suture at approximately 1/3 point on the anterior descending branch of the left coronary artery at a depth of approximately 1.5 mm. If the color of the distal part of the suture became darker, the ST segment of the electrocardiogram (ECG) was elevated, which indicated that a successful model had been established [19] . The mice of the sham group were threaded but not treated by ligation. The blood pressure and heart rate before and after model establishment were tested using a blood pressure measuring instrument.
Enzyme-Linked Immunosorbent Assay (ELISA)
After 24 h of successful model establishment, 0.5 ml of blood samples was collected, kept in a 2-ml test tube, and placed in a refrigerator at 4°C for 15 min. Next, the samples were centrifuged at 8000 r/min for 10 min to collect the serum. According to the instructions for the ELISA Kit, the serum levels of troponin T (TnT), troponin I (TnI), N-terminal pro-B-type natriuretic peptide (NT-proBNP), creatine kinase isoenzyme myocardial band (CK-MB), myoglobin (MYO), tumor necrosis factor-alpha (TNF-α), and interleukin (IL)-1β of supernatant were, respectively, detected using Ek-M20983, ml024897, Ek-M20071, Ek-M20515, ml101811, Ek-M21159 and Ek-M20166 ELISA Kits (all from Shanghai Enzyme Research Biotechnology Co., Ltd., Shanghai, China). The ELISA Kits were equilibrated at room temperature for 20 min, and the washing liquid was prepared. After the standard product was dissolved, 100 µl of it was added to a reaction plate to determine the standard curve. Additionally, 100 µl of the sample to be tested was added to the reaction well for incubation at 37°C for 90 min. The sample was washed, 100 µl of biotinylated antibody working fluid was added, and the sample was incubated at 37°C for 60 min. Next, the sample was washed again, and 100 µl of enzyme-bound working fluid (protected from light) was added for further incubation at 37°C for 30 min. The plates were washed 3 times and treated with 100 µl of substrate before incubation in the dark at 37°C for 15 min. Subsequently, stop buffer was rapidly added to the sample to terminate the reaction. The optic density (OD) values of each tube were tested at 450 nm via an enzyme marker (BioTek Synergy 2, Winooski, USA) within 3 min. The standard curve was drawn according to the OD values to analyze the serum levels of TnT, TnI, NT-proBNP, CK-MB, MYO, TNF-α, and IL-1β.
Hematoxylin-eosin (HE) staining
Thirty minutes after the physiological index measurement, the mice were killed by breaking their necks, and the myocardial tissue was collected and frozen in liquid nitrogen. After preservation at -80°C, the paraffin blocks were pruned and cut into serial sections (5 μm), which were then placed into an 80°C oven for 1 h. After being cooled, the sections were dewaxed with xylene I for 10 min and xylene II for 5
In situ hybridization (ISH)
The paraffin section of the myocardial tissues was sliced to 44-μm thickness for the following experiment. The miRNA expression in the paraffin was assessed by ISH performed by BioGenex Laboratories Inc. (Fremont, CA) with miRNA ISH probes and Super Sensitive One-step Polymer-horseradish peroxidase (HRP) ISH detection kit on Xmatrx, the fully automated staining system (BioGenex Laboratories). In short, these tissues were pretreated using nucleic acid retrieval (NAR) solution at 85°C for 5 min and at 100°C for 20 min. The tissues were incubated with the hybrid buffer at 42°C for 20 min. Subsequently, the miRNA probe labeled with fluorescein (FAM) was utilized to measure miR-495 expression (100 nM). The nonspecific binding probe was rinsed and removed at 42°C The anti-fluorescein antibody was then added, followed by poly-HRP to detect the probe. Color visualization was performed using diaminobenzidine (DAB) and hematoxylin staining. Under the microscope, a positive cell count < 10% was considered negative, and a positive cell count >10% was considered positive, as determined by a qualitative method.
Terminal deoxy (d)-UTP nick end labeling (TUNEL) staining
The TUNEL staining was applied via an in situ cell apoptosis detection kit (11684795910, Roche, Shanghai, China). The experiment followed the manufacturer's instructions, and the main steps were as follows: the myocardium at the apex of the heart was conventionally dehydrated, fixed, embedded by paraffin and sectioned. A total of 5 paraffin sections were selected from each group, dewaxed by xylene, dehydrated by gradient ethanol, and rinsed with phosphate-buffered saline (PBS) (pH 7.2) 3 times with 5 min for each wash (the same as below). The sections were digested by 20 μg/ml protease K at 37°C for 30 min, rinsed by PBS, and suppressed by 3% H 2 O 2 for 30 min. The sections were treated with 1% citric acid solution containing 0.1% TritonX-100 to remove contaminants located on the cell membrane surface, rinsed with PBS, incubated at 37°C for 60 min, and then treated with 50 μl of the TUNEL reaction mixture. Additionally, the sections were treated with HRP-labeled goat anti-rabbit antibody, incubated at 37°C for 30 min, stained with diaminobenzidine (DAB), dehydrated, hyalinized, mounted, and examined under a microscope. The color image analyzer (BI-2000) was applied for analysis. The sections were observed using a high-power objective lens (× 400). Five views were randomly selected around myocardial damage from each section for counting the number of apoptotic cells through TUNEL staining.
Immunohistochemical assay
The tissue was fixed using 10% formaldehyde solution, conventionally embedded by paraffin, and sliced into 4-μm-thick serial sections. The samples were dewaxed, dehydrated by gradient xylene-alcohol, repaired by 3% H 2 O 2 sodium citrate antigen solution, and then sealed by serum. Additionally, the samples were treated with rabbit anti NLRP3 monoclonal antibody (1: 200, Santa Cruz Biotechnology, Santa Cruz, USA), incubated at 37°C for 1 h and 4°C overnight, and rinsed by PBS 3 times (each for 3 min). In addition, the samples were treated with biotinylated goat anti-rabbit secondary antibody solution (ready-to-use) and incubated at 37°C for 30 min, followed by 3 PBS washes (each for 3 min). The samples were treated with newly prepared DAB (Boster Biological Technology co. ltd, Hubei, China) staining solution for 1 ~ 2 min, followed by 3 PBS washes (each for 2 min). The samples were re-stained by hematoxylin (Keygen Biological Technology Co. Ltd, Jiangsu, China) for 1 min, dehydrated, permeabilized, and mounted by neutral balata. The rate of NLRP3-positive cells for the whole slice was calculated as the mean ± standard deviation.
2, 3, 5-triphenyltetrazolium chloride (TTC) staining
After perfusion, the hearts of mice were removed and crosscut into 5 pieces of 2-mm sections. After being flattened, the sections were added to a 1% TTC solution dissolved by 0.1 mol/L PBS, incubated at 37°C in the dark for 20 min, removed and added to 10% neutral formaldehyde prepared in 0.1 mol/L PBS. The two sides of 4 sections were photographed at the 1 st , 2 nd , 3 rd and 4 th week after the TTC staining. The infarct size of the heart was counted via Photoshop cs6 (Adobe Systems, San Jose, CA, USA). Moreover, the infarct size (%) = infarct size/total area of transverse section × 100%.
Reverse transcription quantitative polymerase chain reaction (RT-qPCR)
Trizol RNA (Invitrogen, Carlsbad, CA, USA) was applied to extract total RNA. Agarose gel electrophoresis was performed to examine the integrity of RNA. The 28S and 18S were bright, clear, sharp bands, and the brightness of the 28S band was more than twice that of the 18S band, suggesting the integrity of the RNS segment. The ratio of A260/A280 of RNA was 2.1 at 260 nm (A260), as detected by the spectrophotometric method. The result suggested the high-purity of RNA. Reverse transcription was conducted using the Primescript TMR Treagent Kit Sensiscript RT-Kit (RRO37A, TaKaRa Biotechnology, Liaoning, China). The steps were as follows: the RNA extract was dissolved in 40 μl of non-RNAase water; and to each 200-μl thinwalled tube without RNAase were added 12 μl of non-RNAase water, 2 μl of OdT and 3 μl of RNA sample. The samples were mixed, heated at 70°C for 5 min, and cooled with ice water for 2 min. The samples were treated with 1 μl of dNTP, 1 μl of RNA enzyme inhibitor, 5 μl of 5 × reverse transcription buffer, and 1 μl of reverse transcriptase MMLV. After gently mixing evenly using a transferpettor, the samples were incubated in a warm bath at 37°C for 90 min, heated at 70°C for 5 min to terminate the reaction, and then preserved on the ice-box for the following experiment. The real-time PCR instrument (ABI 7500, Applied Biosystems Inc. Carlsbad, CA, USA) was used to amplify the target band, and the PCR reaction system was 25 μl including 2.5 μl of 10 × PCR Buffer, 1.5 μl of 25 mmol/L Mgcl 2 , 0.5 μl of 10 mmol/L dNTP, 1 μl/L of 10 mmol/L forward primer, 1 μl/L of 10 mmol/L reverse primer, 0.5 μL/L of Taq, 2.0 cof cDNA, and 16 μl sterile distilled water. The reaction conditions were as follows: 40 cycles of denaturation at 94°C for 5 min, denaturation at 94°C for 30 s, denaturation at 58°C for 45 s, denaturation at 72°C for 30 s, and finally extension at 72°C for 10 min. All reactions included three duplicated wells. The U6 was considered the internal reference of miR-495 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for the other genes. The 2 -ΔΔCt method [20] was used to determine the miR-495 expression and the mRNA expressions of NLRP3, TNF-α, IL-1β and IL-18. The formula used was as follows: the ΔΔCT = ΔT (the CMECs injury group) -ΔCt (the control group) , of which ΔCt = Ct sample RNA -Ct U6/GAPDH . Ct was the number of cycles when the real-time fluorescence intensity of the reaction reached a set threshold. The cell experiments were conducted as above, and the primer sequences are shown in Table 1 .
Western blot analysis
The total protein was extracted from the lysate (C0481, Sigma-Aldrich, St Louis, USA), and the protein was quantified the by bicinchoninic acid (BCA) method. The 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel was prepared, and each well had 20 μg of the protein sample. The samples were mixed with sample loading buffer, boiled at 100°C for 5 min, incubated in an ice-bath, centrifuged and then added equivalently into each lane by a micro-sampler for electrophoretic separation. Subsequently, the protein on the gel was transferred into a nitrocellulose membrane. The membrane was blocked using 5% non-fat milk powder for 1 h and treated with the rabbit anti-NLRP3 (ab214185, Abcam, Cambridge, MA, USA) (1: 500), rabbit anti-TNF-α (ab1793, Abcam, Cambridge, MA, USA) (1: 500), rabbit anti-IL-1β (ab200478, Abcam, Cambridge, MA, USA) and rabbit anti-IL-18β (ab71495, Abcam, Cambridge, MA, USA) (1: 500), followed by incubation at 4°C overnight. The membranes were washed with Trisbuffered saline-Tween (TBST) 3 times (each for 15 min) the next day. The membranes were incubated with HRP-labeled goat anti-rabbit IgG (Beijing ComWin Biotech Co., Ltd., Beijing, China) (diluted by 1: 500) at room temperature for 1.5 h, followed by TBST washing. The chemiluminescence method (NCI4106, Pierce Biotechnologies, Rockford, IL, USA) was applied to observe the protein expression. Beta-actin (β-actin) was considered the internal reference, the first antibody was the mouse anti-β-actin (ab8226, Abcam, Cambridge, MA, USA) (1: 500), the second antibody was the HRP-labeled goat anti-rabbit IgG (1: 2000) (Beijing ComWin Biotech Co., Ltd., Beijing, China), and the method of incubation was the same as above. The relative expressions of NLRP3, TNF-α, IL-1β and IL-18 were calculated as the ratio of the absorbance value of the bands for NLRP3, TNF-α, IL-1β and IL-18 and the value of the β-actin band. Additionally, the gray level was analyzed by the ImageJ (Bio-rad) software, and the cell experiments adopted the same method as above.
Cell culture, grouping and transfection
The collected hearts were soaked in plates containing PBS and heparin for 5 min, the hearts were taken out and rinsed with sterile PBS 3 times. After rinsing, the epicardial membranes were removed by ophthalmic scissors, and the myocardial tissue was sheared. The samples were treated with 3 ml of type II collagenase (40508ES60, YEASEN, USA) and digested in a water bath for 6 min. Next, the samples were treated with equal volumes of pancreatin (C0201, Beyotime Biotechnology Inc., Shanghai, China) and digested in a water bath at 37°C for 25 min. After digestion, the samples were treatede with Dulbecco's Modified Eagle Medium (DMEM) culture solution containing fetal bovine serum to terminate the digestion. The samples were filtered using a 100-μm strainer, and the filtrate was centrifuged at 2000 r/min for 10 min at room temperature with the supernatant discarded. The cells were suspended in a complete culture medium and cultured in a 5% CO 2 cell incubator at 37°C. On the day before transfection, the cells were placed on the 12-well plates for reaching 70% fusion. In addition, 50 pmol of has-miR-495 mimic, hsamiR-495 inhibitor, siNLRP3 plasmid and NLRP3 plasmid (Shanghai GenePharma Co., Ltd., Shanghai, China) were added to 2-ml centrifuge tubes, respectively, followed by the addition of 100 μl of Opti-MEM (Thermo Fisher Scientific, MA, USA), respectively, in each group. Next, 1 μl of lipo2000 reagent (Thermo Fisher Scientific, MA, USA) was diluted in 50 μl of Opti-MEM. The diluted reagent was mixed evenly and placed for 5 min; next, the plasmid and lipo2000 diluent were mixed at room temperature for 20 min. The lipo2000 mixture was added into corresponding cell plates. Moreover, the cells were cultured for 6 h, followed by the replacement of the new culture medium. After transfection for 48 h, the cells were collected and assigned to the normal group (cells from normal mice, without transfection), the blank group (cells from model mice, without transfection), the negative control (NC) group (transfected with the empty plasmid), the miR-495 mimic group (transfected with miR-495 mimic plasmid), the miR-495 inhibitor group (transfected with miR-495 inhibitor plasmid), the siNLRP3 group (transfected with siNLRP3 plasmid), the pcDNA3.1-NLRP3 group, or the miR-495 inhibitor + siNLRP3 group (transfected with inhibitor and siNLRP3 plasmid) for subsequent experimental analysis.
Construction of overexpression vector of NLRP3 gene
The RNA from the cells was extracted by the Trizol method, and NLRP3 sequences were designed for the RT-PCR reaction. The reaction conditions were as follows: at 94°C for 3 min, 94°C for 30 s, 60°C for 30 s, 72°C for 30 s with 30 cycles, and 72°C for 10 min. The 1.5% agarose gel electrophoresis method was used to observe the results and separate the PCR products. Subsequently, the products were recovered and purified according to the method provided by Gel Recovery Kit. The recovered products were connected with pcDNA3.1/VS-His-TOPO eukaryotic expression vector (K480001, Invitrogen Corporation, Carlsbad, CA, USA). Next, the samples were transformed into TOP10 competent bacteria (C404003, Invitrogen Corporation, Carlsbad, CA, USA). The positive clones were selected, and the plasmids were identified by sequencing.
Results
The blood pressure and heart rate of mice before and after model establishment First, the blood pressure and heart rate of mice were measured both before and after model establishment for comparison. There were 15 mice with a 75% success rate for model establishment. After model establishment, the heart rate had no significant change (P > 0.05), and the blood pressure was significantly declined (P < 0.05) ( Table 2 ).
An increase of levels of TnT, TnI, NT-proBNP, CK-MB, MYO, TNF-α and IL-1β are observed in mice with myocardial I/R injury Next, the TnT, TnI, NT-proBNP, CK-MB, MYO, TNF-α and IL-1βs serum levels were determined in each group by ELISA. Compared with the sham group, the serum levels of TnT, TnI, NT-proBNP, CK-MB, MYO, TNF-α and IL-1β in the MIR group obviously increased (all P < 0.05) ( Table 3) . Therefore, mice with myocardial I/R injury have higher levels of TnT, TnI, NT-proBNP, CK-MB, MYO, TNF-α and IL-1β.
Histopathological observation of myocardial tissue in mice with myocardial I/R injury
Subsequently, HE staining was utilized to observe the histopathological features of the myocardial tissue of mice with myocardial I/R injury. The results of the HE staining showed that the sham group had neatly arranged myocardial cells without obvious hyperplasia and hypertrophy, relatively balanced nuclear sizes, and no obvious hyperplasia of collagen fibers. However, the myocardial cells of the MIR group were in disorderly arrangement with obvious hyperplasia and hypertrophy and obviously increased hyperplasia of collagen fibers (Fig. 1) .
Mice with myocardial I/R injury have increased cell apoptosis rate
TUNEL staining was applied for determining the effect of myocardial I/R injury on apoptosis. As shown in Fig. 2 , the results of the TUNEL staining indicated that apoptotic positive cells were dark brown, with the nuclei showing atrophy, the chromatin gathered at the edge, and the cytoplasm was not stained. Apoptotic cells in the sham group [(1.29 ± 0.11)%] were lower than that in the MIR group [(15.94 ± 1.31)%] (P < 0.05). Therefore, we can conclude that apoptosis was exaggerated by myocardial I/R injury. Table 3 . Changes in the levels of inflammatory factors (TnT, TnI, NT-proBNP, CK-MB, MYO, TNF-α and IL-1β) in the sham and experiment groups. Notes. MIR, myocardial ischemia/reperfusion injury; TnT, Troponin T; TnI, troponin I; CK-MB, creatine kinase isoenzyme MB; MYO, myoglobin; NT-proBNP, N-terminal pro-B-type natriuretic peptide; TNF-α, tumor necrosis factor-alpha; IL-1β, interleukin 1beta; *, P < 0.05, compared with the sham group
TnT pg/ml TnI g/ml CK-MB ng/ml MYO ng/ml NT-proBNP pg/ml TNF-α pg/ml IL-1β pg/ml Sham 0.02 ± 0.01 0.02 ± 0.01 0. 
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The positive expression of miR-495 is lower in mice with myocardial I/R injury
Since miR-495 has been reported to exhibit abnormal expression in myocardial diseases, its expression was detected by an in situ hybridization experiment. When the cytoplasm was visualized as blue-purple, the cells were considered to exhibit positive expression of miR-495. Of the 15 cases in the sham group, 3 positive cases were found to have a positive rate of 15.00%, and in the 11 cases in the MIR group, 11 positive cases were identified to have a positive rate of 85.00%. Compared to the sham group, the positive expression of miR-495 increased significantly in the MIR group (Fig. 3) . It is revealed that there is a decline of positive expression of miR-495 in mice with myocardial I/R injury. Positive expression of NLRP3 is lower in mice with myocardial I/R injury NLRP3 had additionally been investigated in myocardial diseases with correlation with miRNAs; therefore, the next step was to measure the positive expression of NLRP3 in each group using immunohistochemistry. The CMECs characterized by different degrees of brown granules under a light microscope were the positive cells; otherwise, the results of staining showed the negative cells (Fig. 4) . As shown in Fig. 4 
NLRP3 was verified as the target gene of miR-495
The relationship between miR-495 and NLRP3 was investigated next. The biological prediction website microRNA.org showed that miR-495 targeted and suppressed NLRP3. There were sequences of the 3'-UTR region of the NLRP3 mRNA binding with miR-495 (Fig.  7A) . Furthermore, the dual-fluorescent reporter gene system indicated that luciferase signal of the pmTOR-Wt co-transfection group in the miR-495 mimic group decreased markedly compared with the other groups (P < 0.05); however, the luciferase signal of pmTOR-Mut in each group showed no significant difference (P > 0.05) (Fig. 7B) . Thus, miR-495 could target the NLRP3 mRNA via the negative regulation of its expression. 
MiR-495 suppressed NLRP3, TNF-α, IL-1β, IL-18 and caspase-1 expression, whereas NLRP3 had the opposite effect on TNF-α, IL-1β, IL-18 and caspase-1
In addition, the role of miR-495 on NLRP3 and the functions of miR-495 and NLRP3 on TNF-α, IL-1β, IL-18 and caspase-1 were studied. Compared with the normal group, miR-495 expression decreased, but the mRNA expression of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1 obviously increased in the blank, NC, miR-495 mimic, miR-495 inhibitor, miR-495 inhibitor + siNLRP3, siNLRP3, and pcDNA3.1-NLRP3 groups (P < 0.05). No significant difference was found in the mRNA expression of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1 among the blank, NC, and miR-495 inhibitor + siNLRP3 groups or between the miR-495 inhibitor and pcDNA3.1-NLRP3 groups (all P > 0.05). Compared with the blank and the NC groups, the miR-495 expression increased considerably in the themiR-495 mimic group (P < 0.05), but the result was opposite to that in the miR-495 inhibitor group (P < 0.05). Compared with the blank and NC groups, the mRNA expression of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1 clearly decreased in the miR-495 mimic and siNLRP3 groups. In contrast, the mRNA expression of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1 increased significantly in the miR-495 inhibitor and pcDNA3.1-NLRP3 groups (all P < 0.05) (Fig. 8) . Therefore, miR-495 negatively impacted the miRNA expression of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1, whereas NLRP3 positively impacted TNF-α, IL-1β, IL-18 and caspase-1 miRNA expression. In addition to the mRNA expression, the protein expression of important factors was evaluated. The protein expression of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1 increased significantly in the blank, NC, miR-495 mimic, miR-495 inhibitor, miR-495 inhibitor + siNLRP3, siNLRP3, and pcDNA3.1-NLRP3 groups compared to the normal group (P < 0.05). No significant difference was observed in the protein expression of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1 among the blank, NC, and miR-495 inhibitor + siNLRP3 groups or between the miR-495 inhibitor and pcDNA3.1-NLRP3 groups (all P > 0.05). Compared with the blank and the NC groups, the protein expression decreased clearly in the miR-495 mimic and siNLRP3 groups but increased in the miR-495 inhibitor and pcDNA3.1-NLRP3 groups (all P < 0.05) (Fig. 9) . The influence of miR-495 and NLRP3 on protein expression was the same as that observed for miRNA expression.
Overexpression of miR-495 or silenced NLRP3 promoted cell proliferation
The involvement of miR-495 and NLRP3 in cell proliferation was evaluated using the MTT assay. The cell proliferation increased with culture time. Compared with the normal group, the cell proliferation clearly declined in the blank, NC, miR-495 mimic, miR-495 inhibitor, miR-495 inhibitor + siNLRP3, siNLRP3 and pcDNA3.1-NLRP3 groups (P < 0.05). There was no obvious difference among the blank, NC and miR-495 inhibitor + siNLRP3 groups or between the miR-495 inhibitor and pcDNA3.1-NLRP3 groups (P > 0.05). Moreover, the cell proliferation increased significantly in the miR-495 mimic and siNLRP3 groups compared with the blank and NC groups (all P < 0.05), but it obviously decreased in the miR-495 inhibitor and pcDNA3.1-NLRP3 groups (all P < 0.05) (Fig. 10 ). The conclusion was thus Overexpression of miR-495 or silenced NLRP3 prolonged the G0/G1 phase and shortened the S phase Changes in the G 0 /G 1 phase and S phase were next evaluated using flow cytometry. Cells at the G 0 /G 1 phase obviously increased, and cells at the S phase significantly decreased in the blank, NC, miR-495 mimic, miR-495 inhibitor, miR-495 inhibitor + siNLRP3, siNLRP3 and pcDNA3.1-NLRP3 groups compared to the normal group (P < 0.05). No significant changes in cells at the G 0 /G 1 phase were observed among the blank, NC, and miR-495 inhibitor + siNLRP3 groups or between the miR-495 inhibitor and shNLRP3 groups (P > 0.05). Compared with the blank and NC groups, the miR-495 mimic and siNLRP3 groups clearly had fewer cells at the G 0 /G 1 phase (P < 0.05) and apparently increased cells at the S phase (P < 0.05). Meanwhile, cells at the G 0 /G 1 phase in the miR-495 inhibitor and pcDNA3.1-NLRP3 groups exhibited no obvious difference (P > 0.05) (Fig. 11, Table 4 ). Therefore, increased miR-495 and repressed NLRP3 promotes cell cycle progression.
Overexpression of miR-495 or silenced NLRP3 inhibited cell apoptosis
Finally, differences in cell apoptosis caused by miR-495 and NLRP3 were detected by flow cytometry. Compared with the normal group, cell apoptosis significantly increased in the blank, NC, miR-495 mimic, miR-495 inhibitor, miR-495 inhibitor + siNLRP3, siNLRP3, and pcDNA3.1-NLRP3 groups (P < 0.05). No significant difference in apoptosis was observed among the blank, NC and miR-495 inhibitors + siNLRP3 groups or between the miR-495 inhibitor and pcDNA3.1-NLRP3 groups (P > 0.05). The miR-495 mimic and siNLRP3 groups demonstrated clearly decreased cell apoptosis, while the miR-495 inhibitor and pcDNA3.1-NLRP3 groups showed the opposite results compared to the normal group (all P < 0.05) (Fig. 12, Table 5 ). It is clear that the effects of increased miR-495 or silenced NLRP3 on cell apoptosis were opposite to those on cell proliferation.
Discussion
Myocardial infarction is reported to be the major cause of death in the world, and over the last two decades, coronary reperfusion therapy has been developed for managing acute myocardial infarction [21] . Endothelial cell damage caused by inflammatory factors plays a crucial role in the pathogenesis of numerous vascular diseases [22] . The total difference in the slope of the increase in systolic blood pressure per minute, the systolic blood pressure, and maximal systolic blood pressure during exercise in quintiles have been correlated with the risk of acute myocardial infarction [23] . In our study, we aimed to elucidate the effect of miR-495 on CMEC injury and inflammation reaction through mediating the NLRP3 inflammasome signaling pathway. Subsequently, our study concluded that the overexpression of miR-495 ameliorated CMEC injury and inflammation reaction by suppressing the NLRP3 inflammasome signaling pathway.
In our study, mice in the MIR group exhibited decreased blood pressure and increased infarct size, NLRP3-positive expression and levels of TnT, TnI, NT-proBNP, CK-MB, MYO, TNF-α and IL-1β. Cardiac TnT tested with a strongly sensitive assay was correlated with structural heart diseases and the subsequent development of all-cause mortality [24] . Troponin is primarily used for detecting minor myocardial damage, whereas repeated measurements of CK and CK-MB are used to examine infarct size in patients with myocardial infarction; a very high relation was shown between the peak level and area under the curve of TnT, CK, and CK-MB [25] . Meanwhile, MYO, an early indicator of acute myocardial infarction, plays a primary function in the urgent diagnosis for cardiovascular diseases [26] . Moreover, the mRNA and protein levels of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1 increased significantly, but miR-495 expression decreased markedly in the experiment group. TNF-α has been indicated [27] . The infarct size in TNF-α knockout mice was obviously reduced compared to WT mice [28] . IL-1β and IL-18 are critical mediators in inflammation, and a defective regulation of their release might lead to serious diseases [29] . Furthermore, high IL-18 levels relate to an increased risk of cardiovascular disease (CVD) and a more serious prognosis in patients with constituted CVD [30] .
Moreover, compared with the blank and NC groups, miR-495 expression was increased significantly in the miR-495 mimic group, while the mRNA expressions of NLRP3, TNF-α, IL-1β, IL-18 and caspase-1 were decreased significantly in the miR-495 mimic and siNLRP3 groups. Inflammasomes are defined as multiple protein complexes that act as molecular platforms to induce caspase-1 and control the maturation of a potent proinflammatory cytokine IL-1β, pyroptosis and proinflammatory cell death [31] . The NLRP3 inflammasome is a multiprotein compound that comprises three types of proteins, NLRP3, ASC, and procaspase-1, and is involved in sensing pathogens and serious signals in the innate immune system [32] . TNF-α is crucially concerned with the pathogenesis and procedures of heart failure and myocardial ischemia/reperfusion injury [33] . The NLRP3 inflammasome also modulates IL-1β maturation and secretion in another disease of metabolic dysregulation: gout [34] . Active IL-1β is a vital product of the inflammasome and is cleaved via active caspase-1 [35] . Activation of the NLRP3 inflammasome in calcineurin transgene mice improves systolic dysfunction and myocardial inflammation by producing the pro-inflammatory IL-1β [36] . NLRP3 plays a protective role in age-related macular degeneration via the induction of IL-18 through drusen components [37] . In endothelial cells, the NLRP3 inflammasome exhibits a significant initiating mechanism, and its activation may accelerate the development of endothelial dysfunction or atherogenic pathology by inducing plasma trimethylamine-Noxide (TMAO) [38] . The repression of the NLRP3 inflammasome is a critical factor in I/R or inflammation by correlation with SIRT1, which was proved to be involved in both preventing cells from injury induced by various stress and improving endothelial precursor cell function [39, 40] . Activating the NLRP3 inflammasome signaling can promote atherosclerosis pathogenesis via the overexpression of inducible endothelial-specific GPR124 [41] . In a previous study of ischemic acute kidney injury (AKI), the deficiency of NLRP3 served as a protective factor against mortality, renal dysfunction, and neutrophil influx of mice [42] . Furthermore, our study demonstrated that NLRP3 was the target gene of miR-495, which suggests that overexpressed miR-495 may have the same function as silenced NLRP3.
Finally, we observed that cell proliferation significantly increased but cell apoptosis decreased in the miR-495 mimic and siNLRP3 groups, and the opposite results were found in the miR-495 inhibitor and pcDNA3.1-NLRP3 groups. The study showed that miR-495 and miR-551a suppressed the invasion and migration of human gastric cancer cells by directly mediating with phosphatase of regenerating liver-3 [43] . MiR-22 restrains apoptosis and improves cell activity in endothelial cell (EC) injury under coronary heart disease (CHD) stress, and the role of NLRP3 is the opposite [44] . Moreover, the NLRP3 inflammasome regulates contrast-media-induced acute kidney damage through controlling cell apoptosis [45] . In addition, the NLRP3 inflammasome is up-modulated in myocardial fibroblasts postmyocardial infarction and might be an important contributor to development of infarct size during I/R [46] .
Conclusion
Collectively, our study demonstrated that miR-495 ameliorated CMEC injury and inflammation reaction through suppressing the NLRP3 inflammasome signaling pathway. The mechanisms underlying the inhibitory effect of miR-495 may be related to the regulation of the NLRP3 inflammasome. The findings obtained in this study provide a significant insight into the protective effect of miR-495 and suggest a new approach of utilizing the antiinflammatory effects of miR-495 to treat CMEC injury and inflammatory reaction. However,
